tetano
Editor, Senior Moderator
Vaccine
. 2021 Nov 18;S0264-410X(21)01445-6.
doi: 10.1016/j.vaccine.2021.11.011. Online ahead of print.
Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic
Ismael R Ortega-Sanchez[SUP] 1 [/SUP], Joshua A Mott[SUP] 2 [/SUP], Wanitchaya Kittikraisak[SUP] 3 [/SUP], Viengphone Khanthamaly[SUP] 4 [/SUP], Margaret McCarron[SUP] 5 [/SUP], Soukphadeth Keokhonenang[SUP] 6 [/SUP], Phonepaseuth Ounaphom[SUP] 7 [/SUP], Chansay Pathammavong[SUP] 6 [/SUP], Kongxay Phounphenghack[SUP] 6 [/SUP], Panome Sayamoungkhoun[SUP] 6 [/SUP], Phetsavanh Chanthavilay[SUP] 8 [/SUP], Joseph Bresee[SUP] 9 [/SUP], Chankham Tengbriacheu[SUP] 6 [/SUP]
Affiliations
Abstract
Background: Pregnant women, healthcare workers (HW), and adults >= 60 years have shown an increased vulnerability to seasonal influenza virus infections and/or complications. In 2012, the Lao People's Democratic Republic (Lao PDR) initiated a national influenza vaccination program for these target groups. A cost-effectiveness evaluation of this program was undertaken to inform program sustainability.
Methods: We designed a decision-analytical model and collected influenza-related medical resource utilization and cost data, including indirect costs. Model inputs were obtained from medical record abstraction, interviews of patients and staff at hospitals in the national influenza sentinel surveillance system and/or from literature reviews. We compared the annual disease and economic impact of influenza illnesses in each of the target groups in Lao PDR under scenarios of no vaccination and vaccination, and then estimated the cost-effectiveness of the vaccination program. We performed sensitivity analyses to identify influential variables.
Results: Overall, the vaccination of pregnant women, HWs, and adults >= 60 years could annually save 11,474 doctor visits, 1,961 days of hospitalizations, 43,027 days of work, and 1,416 life-years due to laboratory-confirmed influenza illness. After comparing the total vaccination program costs of 23.4 billion Kip, to the 18.4 billion Kip saved through vaccination, we estimated the vaccination program to incur a net cost of five billion Kip (599,391 USD) annually. The incremental cost per life-year saved (ICER) was 44 million Kip (5,295 USD) and 6.9 million Kip (825 USD) for pregnant women and adults >= 60 years, respectively. However, vaccinating HWs provided societal cost-savings, returning 2.88 Kip for every single Kip invested. Influenza vaccine effectiveness, attack rate and illness duration were the most influential variables to the model.
Conclusion: Providing influenza vaccination to HWs in Lao PDR is cost-saving while vaccinating pregnant women and adults >= 60 is cost-effective and highly cost-effective, respectively, per WHO standards.
Keywords: Adults >= 60 years; Cost-effectiveness; Healthcare worker; Influenza; Lao PDR; Pregnancy; Risk group; Vaccination.
. 2021 Nov 18;S0264-410X(21)01445-6.
doi: 10.1016/j.vaccine.2021.11.011. Online ahead of print.
Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic
Ismael R Ortega-Sanchez[SUP] 1 [/SUP], Joshua A Mott[SUP] 2 [/SUP], Wanitchaya Kittikraisak[SUP] 3 [/SUP], Viengphone Khanthamaly[SUP] 4 [/SUP], Margaret McCarron[SUP] 5 [/SUP], Soukphadeth Keokhonenang[SUP] 6 [/SUP], Phonepaseuth Ounaphom[SUP] 7 [/SUP], Chansay Pathammavong[SUP] 6 [/SUP], Kongxay Phounphenghack[SUP] 6 [/SUP], Panome Sayamoungkhoun[SUP] 6 [/SUP], Phetsavanh Chanthavilay[SUP] 8 [/SUP], Joseph Bresee[SUP] 9 [/SUP], Chankham Tengbriacheu[SUP] 6 [/SUP]
Affiliations
- PMID: 34802790
- DOI: 10.1016/j.vaccine.2021.11.011
Abstract
Background: Pregnant women, healthcare workers (HW), and adults >= 60 years have shown an increased vulnerability to seasonal influenza virus infections and/or complications. In 2012, the Lao People's Democratic Republic (Lao PDR) initiated a national influenza vaccination program for these target groups. A cost-effectiveness evaluation of this program was undertaken to inform program sustainability.
Methods: We designed a decision-analytical model and collected influenza-related medical resource utilization and cost data, including indirect costs. Model inputs were obtained from medical record abstraction, interviews of patients and staff at hospitals in the national influenza sentinel surveillance system and/or from literature reviews. We compared the annual disease and economic impact of influenza illnesses in each of the target groups in Lao PDR under scenarios of no vaccination and vaccination, and then estimated the cost-effectiveness of the vaccination program. We performed sensitivity analyses to identify influential variables.
Results: Overall, the vaccination of pregnant women, HWs, and adults >= 60 years could annually save 11,474 doctor visits, 1,961 days of hospitalizations, 43,027 days of work, and 1,416 life-years due to laboratory-confirmed influenza illness. After comparing the total vaccination program costs of 23.4 billion Kip, to the 18.4 billion Kip saved through vaccination, we estimated the vaccination program to incur a net cost of five billion Kip (599,391 USD) annually. The incremental cost per life-year saved (ICER) was 44 million Kip (5,295 USD) and 6.9 million Kip (825 USD) for pregnant women and adults >= 60 years, respectively. However, vaccinating HWs provided societal cost-savings, returning 2.88 Kip for every single Kip invested. Influenza vaccine effectiveness, attack rate and illness duration were the most influential variables to the model.
Conclusion: Providing influenza vaccination to HWs in Lao PDR is cost-saving while vaccinating pregnant women and adults >= 60 is cost-effective and highly cost-effective, respectively, per WHO standards.
Keywords: Adults >= 60 years; Cost-effectiveness; Healthcare worker; Influenza; Lao PDR; Pregnancy; Risk group; Vaccination.